M

Author

Marcus Chen

Markets & Equities Correspondent

Marcus Chen has covered global equity markets for 12 years, reporting on earnings season, stock listings, and corporate deal activity across US and Asian exchanges. He holds a CFA charter and previously worked as an equity research associate at a Singapore brokerage before moving into financial journalism. His reporting focuses on translating quarterly results and M&A activity into plain-language coverage for retail investors.

Covers:
  • stocks
  • markets
  • earnings
  • mergers-acquisitions
Latest by Marcus Chen
UBS Upgrades DocMorris to Neutral on Improving Margin Outlook

Stocks

UBS Upgrades DocMorris to Neutral on Improving Margin Outlook

Jul 20, 2026

UBS has raised its rating on online pharmacy DocMorris to 'Neutral' from 'Sell,' citing a developing track record of margin improvement and a more favorable sales mix. The bank also significantly increased its price target, though it remains cautious on the company's path to positive free cash flow.